Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Combination therapy improves urinary flow and reduces residual urine, but needs better stent design.

Combining α-blockers with 5α-reductase inhibitors improves symptoms and outcomes for severe benign prostatic hyperplasia.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Dutasteride is more effective than Finasteride in reducing prostate size and PSA levels, but both drugs have similar side effects.

Finasteride safely treats enlarged prostate and male-pattern baldness.

5-ARI therapy may help prevent prostate cancer progression.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Finasteride helps female-pattern hair loss.

Long-term treatment with finasteride or combined therapy worsens sexual function in men with urinary issues.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

FCE 28260 is a stronger and longer-lasting inhibitor of 5α-reductase than finasteride, which may make it a better treatment for certain medical conditions.

5α-reductase inhibitors help treat prostate enlargement and hair loss but may cause side effects, requiring careful use.

Canadian lawsuits involving 5-alpha-reductase inhibitors are related to persistent erectile dysfunction side effects, with no judgments against companies yet.

LGF injections may improve early Peyronie's disease by reducing penile curvature and plaque size.

Finasteride doesn't affect erections much, but may decrease libido in men.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

New hybrid compound found to effectively prevent hair loss.

5-Alpha reductase inhibitors may prevent prostate cancer but are not widely used due to concerns about trial relevance and potential risks, and more research is needed to confirm long-term benefits.

Long use of finasteride and dutasteride can cause long-term erection problems.

Erectile dysfunction is linked to marital issues in patients with benign prostatic hyperplasia.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

A stronger dual 5α-reductase inhibitor could improve treatment for benign prostatic hyperplasia by further reducing DHT levels.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Medicines called 5-alpha-reductase inhibitors, like finasteride and dutasteride, are useful for treating enlarged prostate and male pattern hair loss.

Using finasteride for hair loss or prostate issues does not significantly raise the risk of erectile dysfunction.